Dumb Money Live

Results Are In! Stock Market Reaction to AstraZeneca Oxford Trial Results

41 min • 21 juli 2020

Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00